Abstract:OBJECT:The present study aimed to clarify the incidence and clinical features of disease progression in adult moyamoya disease (MMD) patients with Graves disease (GD) for better management of these patients.METHODS:During the past 18 years, 320 adult Chinese patients at West China Hospital were diagnosed with MMD, and 29 were also diagnosed with GD. A total of 170 patients (25 with GD; 145 without GD) were included in this study and were followed up. The mean follow-up was 106.4 ± 48.6 months (range 6-216 months). The progression of the occlusive lesions in the major intracranial arteries was measured using cerebral angiography and was evaluated according to Suzuki's angiographic staging. Information about cerebrovascular strokes was obtained from the records of patients' recent clinical visits. Both angiographic progression and strokes were analyzed to estimate the incidences of angiographic progression and strokes using Kaplan-Meier analysis. A multivariate logistic regression model was used to test the effects of sex, age at MMD onset, disease type, strokes, and GD on the onset of MMD progression during follow-up.RESULTS:During follow-up, the incidence of disease progression in MMD patients with GD was significantly higher than in patients without GD (40.0% vs 20.7%, respectively; p = 0.036). The interval between initial diagnosis and disease progression was significantly shorter in MMD patients with GD than in patients without GD (p = 0.041). Disease progression occurred in both unilateral MMD and bilateral MMD, but the interval before disease progression in patients with unilateral disease was significantly longer than in patients with bilateral disease (p = 0.021). The incidence of strokes in MMD patients with GD was significantly higher than in patients without GD (48% vs 26.2%, respectively; p = 0.027). The Kaplan-Meier survival curve showed significant differences in the incidence of disease progression (p = 0.038, log-rank test) and strokes (p = 0.031, log-rank test) between MMD patients with GD and those without GD. Multivariate analysis suggested that GD may contribute to disease progression in MMD (OR 5.97, 95% CI 1.24-33.76, p = 0.043).CONCLUSIONS:The incidence of disease progression in MMD patients with GD was significantly higher than that in MMD patients without GD, and GD may contribute to disease progression in MMD patients. The incidence of strokes was significantly higher in MMD patients with GD than in patients without GD. Management guidelines for MMD patients with GD should be developed.

Association of Thyroid Autoantibodies and Thyroid Function with Moyamoya Disease: a prospective study in Western China

Association of Moyamoya Disease with Thyroid Autoantibodies and Thyroid Function: A Case-Control Study and Meta-Analysis

Elevated Thyroid Autoantibodies And Intracranial Stenosis In Stroke At An Early Age

Thalamic structure and anastomosis in different hemispheres of moyamoya disease

Prevalence of Autoimmune Disease in Moyamoya Disease Patients in Western Chinese Population

Abnormal Brain Functional and Structural Connectivity Between the Left Supplementary Motor Area and Inferior Frontal Gyrus in Moyamoya Disease

Research progress on moyamoya disease combined with thyroid diseases

Association of increased Treg and Th17 with pathogenesis of moyamoya disease

Abstract 51: Peripheral Regulatory T Cells and Th17 Cells is Associated with Pathogenesis of Moyamoya Disease

Association between systemic immune-inflammatory markers and the risk of moyamoya disease: a case-control study

Clinical Features and Disease Progression in Moyamoya Disease Patients with Graves Disease.

Modifiable Risk Factors Associated With Moyamoya Disease

Increased Prevalence of Autoimmune Disease in Patients with Unilateral Compared with Bilateral Moyamoya Disease.

Circulating immune cell landscape and T‐cell abnormalities in patients with moyamoya disease

Moyamoya Disease Associated with Thyroid Carcinoma

Mass cytometry revealed the circulating immune cell landscape across different Suzuki stages of Moyamoya disease

Moyamoya Disease Presenting As Thalamic Infarction in a Patient with Neuromyelitis Optica Spectrum Disorder

Thyroid antibodies are associated with stenotic lesions in the terminal portion of the internal carotid artery

Modifiable Risk Factors Associated With Moyamoya Disease: A Case-Control Study.

Conventional Computed Tomography and Axial Magnetic Resonance T2-Weighted Imaging of Horizontal Segment of Middle Cerebral Artery in Moyamoya Disease or Syndrome in Adult Patients.

Abstract TP284: Transcriptome Profiling of Peripheral Blood Mononuclear Cells in Moyamoya Disease